San Diego, CA, February 17, 2012 --(PR.com
)-- MediPurpose(r), a master medical product distributor and manufacturer, today announced its agreement to provide SurgiLance(r) safety lancets in a special packaging configuration to CLIAwaived, a wholesale point-of-care diagnostics product distributor.
CLIAwaived joins MediPurpose's expanding network of international point-of-care (POC) diagnostics product companies. Within recent months, MediPurpose has announced similar relationships with POC manufacturers and distributors in the United States, the United Kingdom and Austria.
Through its Website, CLIAwaived.com will offer SurgiLance's SLN100 26-gauge safety lancet and SLN200 23-gauge safety lancet.
"The continued adoption of our safety lancets by POC diagnostic testing companies worldwide validates the core values of our medical products: safety, comfort and ease of use," said MediPurpose Director of Marketing Derek Rudnak. "The SLN100 and SLN200 are among the best safety lancets for POC diagnostic blood collection because they can produce appropriate amounts of blood while causing minimal pain to the patient."
The SLN100 and SLN200 are among SurgiLance's six safety lancet models that range from 18-26 gauges and 1.0-2.3 mm penetration depths. Valued for its safety, comfort and ease of use, the SurgiLance safety lancet is one of the top selling fingerstick devices in the United States and is available to healthcare professionals through a broad network of distributors, both in the United States and globally.
What are CLIA-Waived Medical Products?
The term "CLIA waived" originates from the Clinical Laboratory Improvements Amendments (CLIA) law that was passed by the U.S. Congress in 1988. This law established quality standards for all laboratories in order to ensure efficiency of testing procedures, in addition to the accuracy and timeliness of test results. The U.S. Food and Drug Administration (FDA) was designated as the law's regulatory body.
In 1992, when the CLIA law was enacted, provisions were made for tests that were considered to be both simple to administer and reliable in results. These tests were given the designation "CLIA waived" as they are not subject to the same level of regulatory scrutiny as more complex diagnostic tools.
CLIAwaived.com provides customers with access to many of the tests that appear on the waiver list and is known as a "one-stop source" for CLIA-waived POC diagnostics.
For more information about SurgiLance safety lancets, including no-cost product sample requests, please visit http://www.medipurpose.com/surgilance
CLIAwaived has been distributing products throughout the world since 2003. CLIAwaived(tm) services thousands of Certificate of Waiver Labs, physician offices, hospitals, ambulatory care centers, employers, academic research centers, government agencies, schools, rehabilitation programs, youth and criminal justice systems and more.
For more information about CLIAwaived, please visit http://www.cliawaived.com .
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.